# KO (Coca-Cola Company) Stock Analysis — 2026-08-30

> Coca-Cola is executing exceptionally well — Q2 2026 delivered 7% revenue growth, 6% organic growth, 5% volume growth across every segment, 90bps of comparable margin expansion, and a raised full-year EPS growth guide of 9-10%. The business quality is not in question: it is out-executing PepsiCo on t...

- Verdict: **Hold**
- Price at analysis: $89.66
- 1Y price target: $94.00 (+4.8% implied)
- 3Y price target: $106.00 (+18.2% implied)
- Technicals: RSI 58, MACD neutral (stock consolidating just below all-time high after strong uptrend; momentum cooling from overbought)
- Source: https://stockquantai.com/research/ko/2026-08-30

## Executive Summary

Coca-Cola is executing exceptionally well — Q2 2026 delivered 7% revenue growth, 6% organic growth, 5% volume growth across every segment, 90bps of comparable margin expansion, and a raised full-year EPS growth guide of 9-10%. The business quality is not in question: it is out-executing PepsiCo on the health-trend shift, gaining share, and demonstrating genuine pricing power plus volume momentum (Coca-Cola Zero Sugar +16%).

The problem is price, not fundamentals. At ~26-27x forward earnings versus a 5-year average well below that, a 2.4% dividend yield (down from 2.9% at the start of 2026), and a stock up ~27% YTD sitting within 3% of its all-time high, the market is paying a premium multiple for a business guiding to mid-single-digit organic growth. The 30-year Treasury now yields more than KO's dividend, compressing the income thesis. Multiple expansion has done most of the work this year; from here, returns must come from earnings, which compound at high-single digits at best.

My verdict is neutral. This is a wonderful company at a full price. I expect low-to-mid single digit total returns over the next 12 months as the multiple normalizes toward ~25x, and market-level returns over three years as EPS growth (~9-10%/yr) partially offsets valuation compression. There is no catalyst for a major drawdown — the balance sheet, brand moat, and Berkshire anchor are intact — but there is also no margin of safety at $89.66.

## Price Targets

| Horizon | Price | Implied Growth |
|---|---|---|
| 1 Year | $94.00 | +4.8% |
| 3 Year | $106.00 | +18.2% |

## Scenarios

| Scenario | 1Y Price | 3Y Price | Thesis |
|---|---|---|---|
| Hyper Bull | $108.00 | $140.00 | Requires the market to sustain 30x+ earnings on a staples name while KO delivers 10%+ EPS growth and further margin expansion — a re-rating on top of an already rich multiple. Possible only in a defensive-mania rotation; not supported by current growth rates. |
| Bull | $99.00 | $118.00 | KO delivers the raised 9-10% EPS growth guide, the multiple holds at ~26-27x on defensive rotation, and World Cup/fairlife momentum carries into 2027. 1Y: ~$4.30 EPS x 27x ≈ $99 (+10%). 3Y: ~10% annual EPS compounding with only modest multiple compression gets to ~$118. |
| Neutral | $94.00 | $106.00 | Excellent fundamentals are fully priced at 26-27x forward earnings, a 2.4% yield below the 30-year Treasury, and an all-time-high entry. EPS grows ~9-10% but the multiple compresses modestly toward its 5-year average, netting low-single-digit 1Y returns (~$4.25 EPS x 25.5x ≈ $94, +5%). Over 3 years, earnings compounding at ~9% partially offset by valuation normalization yields ~$106 (+18% total, ~6%/yr) — market-like returns without margin of safety. |
| Bear | $80.00 | $82.00 | Multiple mean-reversion dominates: 26-27x compresses to ~22-23x (its historical norm) as rates stay elevated and the pricing tailwind fades. Even with ~$4.20 EPS, 22x ≈ $80-82 (-10%). A consumer slowdown hitting volumes, or GLP-1 impact proving larger than modeled, accelerates the de-rating. |
| Hyper Bear | $68.00 | $62.00 | Requires a consumer recession crushing volumes simultaneously with a de-rating to 16-17x — a 2015-2018-style stagnation episode. The Fairlife cyber incident and EM/FX shocks compound. Low probability given KO's defensive demand profile, but historically KO has spent decade-long stretches flat. |

## Key Metrics

- Market Cap: $385.77B
- P/E Ratio: ~26-27x forward (above 5-year average)
- P/S Ratio: N/A
- Revenue: Q2 2026: $13.4B (+7% YoY)
- Net Income: N/A (Q2 operating income +9%, comparable operating margin 35.6%)
- EPS: Q2 2026 comparable EPS $0.97 (+11%); reported EPS $1.03 (+16%)
- Dividend Yield: 2.4% (down from 2.9% at start of 2026)
- Beta: N/A (typically ~0.6 for KO)
- 52-Week High: $92.49 (-3.1% from high)
- 52-Week Low: $65.35 (+37.2% from low)
- Short Interest: N/A (no elevated short interest data; retail selling noted in June dip coverage)

## Micro Analysis

KO's Q2 2026 was a beat-and-raise quarter: EPS +16% reported / +11% comparable to $0.97, revenue +7% to $13.4B, organic +6%, volume +5% globally with every geographic segment adding volume. Operating margin expanded to 34.9% (35.6% comparable). Full-year comparable EPS growth guidance was raised to 9-10%. The company is winning the GLP-1/health-conscious consumer shift relative to PepsiCo via Zero Sugar momentum and premium hydration (Smartwater, Vitaminwater, Fairlife). Offsetting positives: a ransomware attack on Fairlife (11-day shutdown across four US plants) that the market shrugged off, and post-earnings downward estimate revisions noted in coverage.

- **Beat-and-raise momentum**: Q2 2026: adjusted EPS $0.97 vs $0.93 expected; revenue $13.4B (+7%); organic +6%; unit case volume +5% with all segments positive; comparable operating margin 35.6% vs 34.7%. FY guidance raised to 9-10% comparable EPS growth.
- **Valuation is the constraint**: ~26-27x forward P/E vs a five-year average meaningfully lower; stock up ~27% YTD and within 3.1% of its $92.49 all-time high. Dividend yield compressed to 2.4% from 2.9% at the start of 2026. Multiple expansion, not earnings, drove much of the 2026 rally.
- **Competitive share gains**: KO is decisively out-executing PepsiCo on the sugar-reduction/health trend; Coca-Cola Zero Sugar grew +16% and the fairlife dairy and Powerade (World Cup hydration) assets are performing. Fairlife ransomware incident (Anubis group, 11-day shutdown) caused no lasting demand damage per the Q2 print.
- **Dividend quality vs income competition**: 64 consecutive years of increases, 64% payout ratio (better than PEP's 68%), but the 2.4% yield now sits below the 30-year Treasury yield — a headwind for income-oriented flows that historically supported the multiple.
- **Estimate revisions and post-earnings drift**: Despite the beat, downward estimate revisions were flagged post-earnings and the stock underperformed the S&P 500 in the immediate aftermath — a sign the good news is priced in.

## Macro Analysis

The CPG backdrop has shifted from price-driven to volume-driven growth as core inflation hovers near 2.5% and broad national brand volumes fell 0.6% YTD — a polarized consumer under discretionary pressure. KO is a rare outlier actually growing volume (+5%), which validates its relative strength but also means the sector tailwind from pricing has peaked. GLP-1 adoption and functional-nutrition demand are reshaping beverage preferences, favoring KO's portfolio breadth. Rates matter: with the long bond yielding more than KO's dividend, defensive-income capital has less reason to pay 26x for 5-6% growth.

- **Pricing tailwind has peaked**: Core inflation ~2.5% and CPG pricing-driven growth exhausted; sector unit volumes -0.6% YTD. KO's volume-led +6% organic growth is genuinely impressive relative to peers but the easy margin gains from price are behind it.
- **Rate environment pressures staples multiples**: The 30-year Treasury yield now exceeds KO's dividend yield (2.4%). Defensive bond-proxy valuations face a ceiling when risk-free income competes directly with the dividend.
- **GLP-1 and health-trend secular shift**: Rising GLP-1 use and functional-nutrition demand favor zero-sugar, premium hydration, and protein/dairy (fairlife) — categories where KO has invested early and is winning share vs PepsiCo.
- **Emerging market exposure**: ~60% of revenue is overseas with sizable Latin America and Asia-Pacific contributions — a long-run volume growth engine, but FX remains a recurring translation headwind (comparable currency-neutral operating income +6% vs reported +9% this quarter, though FX was actually a modest tailwind here).
- **Resilient consumer for affordable indulgences**: Even with consumers cutting back elsewhere, beverage demand held up — CEO Braun noted strong demand 'even as consumers cut back in other areas.' A $2-3 drink remains an accessible treat in a slowdown.

## Revenue Opportunities

- **Premium hydration and functional water** (potential: medium): New Smartwater/Vitaminwater electrolyte formulations target a functional water market growing at ~6.95% CAGR to $16.5B by 2035; KO's distribution scale makes it the likely share leader.
- **fairlife and dairy/protein expansion** (potential: high): fairlife has been a multi-year growth engine in high-protein dairy; despite the July ransomware shutdown, demand was intact and capacity additions support continued double-digit contribution to growth.
- **Zero-sugar portfolio and GLP-1-era reformulation** (potential: high): Coca-Cola Zero Sugar +16% volume shows the company captured the health-conscious consumer early; continued innovation in low/no-sugar across the 200-brand portfolio drives both volume and mix.
- **Emerging market penetration** (potential: medium): 60% overseas revenue with deep LatAm/APAC exposure; rising middle-class consumption in India, Southeast Asia, and Africa supports a long runway of volume-led growth.
- **Energy and alcohol-adjacent categories** (potential: low): Coca-Cola's energy portfolio and partnerships (e.g., Topo Chico Hard Seltzer, Jack & Coke RTD) open higher-margin adjacencies, though still small in mix.

## Headwinds

- **Stretched valuation vs growth** (severity: high): ~26-27x forward P/E for 5-6% organic growth guidance and 9-10% EPS growth leaves little room for error; the stock trades within 3% of its all-time high after a 27% YTD run, meaning multiple compression risk dominates.
- **Dividend yield below long Treasury** (severity: medium): Yield compressed to 2.4% from 2.9% in under a year while the 30-year Treasury yields more — income-focused institutional flows that anchor KO's multiple have cheaper alternatives.
- **GLP-1 and sugar-tax secular pressure** (severity: medium): Long-run per-capita soda consumption in developed markets faces structural decline from weight-loss drugs, sugar taxes, and health consciousness; KO is mitigating but not immune.
- **FX and emerging-market volatility** (severity: medium): 60% overseas revenue exposes reported results to dollar strength and EM currency swings; tariffs and geopolitical friction add cost uncertainty.
- **Cybersecurity/operational risk exposed** (severity: low): The Anubis ransomware attack on fairlife (11-day, four-plant shutdown, SEC-filed) revealed operational vulnerability in a key growth asset; repeat incidents could be costlier.

## Tailwinds

- **Volume-led organic growth** (strength: high): 5% global unit case volume growth with every segment positive — rare in a CPG sector with -0.6% YTD volumes — validates real demand strength, not just pricing.
- **Margin expansion and pricing power** (strength: high): Comparable operating margin expanded 90bps to 35.6%; operating income +9%; the concentrate model keeps KO asset-light with best-in-class margins.
- **Raised guidance and World Cup momentum** (strength: medium): FY2026 comparable EPS growth guidance raised to 9-10%; FIFA World Cup activation (Powerade hydration breaks) drove measurable volume and brand engagement.
- **Dividend King credibility** (strength: medium): 64 consecutive years of dividend increases with a sustainable 64% payout ratio; Berkshire's 30+ year anchor position (65% yield on cost) signals durable institutional confidence.
- **Competitive displacement of PepsiCo** (strength: medium): KO got ahead of the health trend while PEP lagged; share gains in zero-sugar CSDs, hydration, and dairy are structural, not cyclical.

## Disclaimer

This report was generated by an AI model and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always conduct your own research and consult a licensed financial advisor before making investment decisions.